General COVID-19 Information
Much has changed on the COVID-19 front since early 2020, though Emory University continues to be at the forefront. Emory closely monitored the COVID-19 outbreak from the beginning. Being geographically positioned right next to the CDC is not a coincidence and is a great metaphor for where we stand ideologically when it comes to infectious diseases and public health. In mid-March 2020, within days after the pandemic was declared, Emory faculty and researchers across a broad gamut of specialties & disciplines pivoted to use their expertise and resources to address a wide array of aspects of COVID-19. The intricate tapestry of COVID-19 activities spans the spectrum of disease – from advancing the understanding of the virus and the body response’s to it , to developing faster and more accurate tests, to finding treatments and prevention modalities. Emory’s work is well positioned to go from bench to bedside because of its outstanding researchers and facilities, which include one of the world’s premier national primate centers, the most comprehensive Vaccine Center, state of the art research laboratories, and a health system that can host clinical trials for the next lifesaving drug or vaccine. Emory’s commitment to the health and safety of our community is paramount. Our experts continue to be on the front lines of the pandemic — caring for patients, researching possible treatments and vaccines, and sharing knowledge to help educate and prepare the public.
Emory COVID-19 Website
The Hope Clinic is part of the Coronavirus Prevention Network (CoVPN), an elite international consortium of researchers that works tirelessly to research countermeasures against COVID-19.
Hope Clinic is an essential component of a nationwide NIH-sponsored effort to better understand the immune responses to COVID-19 in hospitalized patients (IMPACC).
Hope Clinic was one of only 3 sites in the world chosen to conduct the first phase 1 studies of COVID-19 vaccine (Moderna mRNA vaccine) being a Vaccine and Treatment Evaluation Unit (VTEU).
Hope Clinic is one of 100 sites for the larger, 30,000 participant, phase 3 studies of the Moderna mRNA COVID-19 vaccine. We are committed to diversity & inclusion in research and were integral in recruiting a diverse & representative population for the study, achieving greater than 50% racial & ethnic minority enrollment for our site.
Hope Clinic participated in the Janssen and Sanofi COVID-19 vaccine study, and are constantly adding new studies to the list including vaccines for COVID-19 variants and “mix & match” boosters which compare response and outcomes with different combos of COVID-19 vaccine types.
Hope Clinic is the highest enrolling site for MOMI-Vax, currently the only observational U.S. study evaluating safety and antibody response of theauthorized COVID-19 vaccines in pregnant & post-partum women.
- Hope Clinic was the #1 enrolling site for the various phases of the NIH Adaptive COVID Treatment Trial (ACTT).8% of the worldwide study population was enrolled here at Emory and Grady Memorial Hospital
- Hope Clinic was one of the first 3 sites that started the first monoclonal antibody study in the US for treatment and prevention of COVID-19 and participated in Regeneron and Lilly trials.
- In a partnership between Hope Clinic and Grady’s Ponce Clinic, Emory enrolled the highest number of subjects for COMPASS – Community Prevalence of SARS-CoV-2 Study (CoVPN 5002) – a large observational study of 58,000 Americans evaluating the presence of COVID-19 in certain communities & assessing the impact of different policies, education, & interventions in order to guide SARS-CoV-2 prevention measures.
COVID-19 Studies
Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
RECOVER researchers are studying Long COVID and other types of PASC (post-acute sequelae of SARS-CoV-2 infection). PASC is the name for all the long-term health effects that people may have after getting COVID.
Basic Qualifications:
- Ages 18+
- Tested positive for COVID in the last 30 days
ACTIV-6 is testing medications that are already approved for other diseases to learn if they can help people with mild-to-moderate COVID-19 feel better faster and stay out of the hospital.
Basic Qualifications:
- Adults aged 30+
- Tested positive for COVID-19 in the past 10 days
- Have at least 2 COVID-19 symptoms
To participate or for more information please contact Cecilia Zhang at (404) 638-5028 or email cecilia.xi.zhang@emory.edu
Volunteer for a COVID-19 Study
Recruiting participants for studies and engaging with the community are what make the research we do possible. Volunteers enable us to carry out our critical mission here at the Hope Clinic. Please fill out this survey if you are interested in participating in any of our studies involving COVID-19 research.
